Oroxylum indicum for Health & Longevity - Quick Reference Sheet

Oroxylum indicum for Health & Longevity

Created on 07/30/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

A traditional Asian tree bark rich in plant compounds, now sold as a brain-support supplement. One small study in older adults found modest memory gains, but it was maker-funded. Other benefits rest on cell and animal work. Generally well tolerated; the main cautions are theoretical, and long-term safety is unstudied. A low-cost, low-acute-risk experiment to monitor. (Full Review)

Protocol

Dose
500 mg twice daily
Bark extract standardized to oroxylin A (1,000 mg/day), mirroring the human trial; conservative use 100–300 mg
Timing
Morning / early afternoon
Mildly stimulating; late-day dosing may interfere with sleep
Schedule
Split, twice daily
Short half-life of the active baicalein supports split rather than single dosing
Time to effect
Memory & cognition
~12 weeks
When memory gains were measured in the human trial
Subjective change
Several weeks
No acute effect; not a fast, stimulant-like change

Benefits

Contraindications
  • Pregnancy or breastfeeding
  • Bleeding disorders or scheduled surgery (stop 2 weeks prior)
  • Anticoagulant use (e.g., warfarin) unless supervised
  • Hormone-sensitive conditions
  • Children
Key Interactions
  • Anticoagulant and antiplatelet drugs (warfarin, apixaban, clopidogrel, aspirin)
  • Antidiabetic drugs (metformin, sulfonylureas, insulin)
  • Narrow-therapeutic-index drugs cleared by CYP enzymes (certain statins, immunosuppressants, some benzodiazepines)
  • Sedatives and central-nervous-system depressants (benzodiazepines, alcohol, sleep aids)
  • NSAIDs (ibuprofen) and aspirin; sedating antihistamines
  • Blood-thinning supplements (fish oil, ginkgo, garlic, high-dose vitamin E)
  • Glucose-lowering supplements (berberine, cinnamon)
  • Dopaminergic or MAO-B-affecting nootropics
  • Iron supplements (separate by 2 hours)

Risk & Side Effects

  • High: [risks_high]
  • Medium: Gastrointestinal discomfort, headache
  • Low: Increased bleeding tendency, drug-metabolism interactions
  • Speculative: Hormonal effects, reduced iron absorption, additive sedation or overstimulation, unknown long-term safety

Monitoring

Marker Target Why
Fasting glucose 75–90 mg/dL Detects additive blood-sugar lowering, especially if diabetic
HbA1c < 5.4% Tracks longer-term glucose effect
ALT / AST ALT < 25 (men) / < 20 (women) U/L Screens for liver stress with long-term herbal use
hs-CRP < 1.0 mg/L Gauges whether the anti-inflammatory effect is meaningful
Ferritin / iron studies Ferritin 50–150 ng/mL Watches for reduced iron status given baicalein's iron binding
Platelet count / CBC Within lab reference range Baseline before combining with blood-affecting agents

Cadence: Optional baseline; re-check relevant labs at ~3 months, then every 6–12 months if use continues; reassess subjective cognitive benefit at 8–12 weeks

Qualitative Assessment

  • Memory and recall in daily tasks (names, appointments, where items were placed)
  • Mental focus, motivation, and processing speed
  • Mood and stress resilience
  • Sleep quality (to catch any dosing-related disruption)
  • Energy levels through the day